MetaCap

Schrodinger (SDGR) vs First Tracks Biotherapeutics (TRAX)

Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Nov 22, 2026.

Summary

First Tracks Biotherapeutics is the larger company by market cap ($1.75 billion vs $1.72 billion), about 1.0 times the size.

Summary generated from market data by MetaCap's automated system. Methodology

Relative performance

SDGR+99.05%TRAX+119.16%
+200%+85%-30%
Apr 6, 20261 yearNov 20, 2026
SDGR+101.67%TRAX+77.19%
+177%+67%-42%
Apr 6, 20265 yearsNov 16, 2026

Percent change in share price from the first common trading day shown; excludes dividends.

Head-to-head

SDGR versus TRAX key metrics
MetricSDGRTRAX
Share price$22.93$41.64
Market cap$1.72B$1.75B
1-day change-12.95%-6.34%
YTD return+28.24%—
1-year return+39.22%—
5-year return-42.01%—
EPS (TTM)$-0.79$-4.71
Dividend yield0.00%0.00%
Annual dividend$0.00$0.00
Revenue (latest FY)$255.87M—
Revenue growth (YoY)+23.29%—
Net income (latest FY)$-103.27M—
Gross margin55.74%—
Operating margin-65.23%—
Net margin-40.36%—
52-week high$34.00$54.78
52-week low$10.95$14.72
Distance from 52-week high-32.56%-23.99%
Analyst consensusbuystrong_buy
Avg. price target upside+46.40%+80.52%
Average volume2.08M826.70K
Shares outstanding65.91M42.02M
Employees850104
SectorHealth CareHealth Care
IndustryBiotechnology: Pharmaceutical PreparationsBiotechnology: Pharmaceutical Preparations

Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.

About Schrodinger

SDGR stock →

Schrödinger, Inc., together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications in the United States, the Asia-Pacific, Europe, Middle East, Africa, and internationally. The company operates in two segments, Software and Drug Discovery.

Health Care · Biotechnology: Pharmaceutical Preparations · 850 employees

About First Tracks Biotherapeutics

TRAX stock →

First Tracks Biotherapeutics, Inc. operates a clinical-stage biotechnology company focused on delivering immunology therapeutics for autoimmune and inflammatory diseases in United States.

Health Care · Biotechnology: Pharmaceutical Preparations · 104 employees

SDGR vs TRAX FAQ

Which is bigger, Schrodinger or First Tracks Biotherapeutics?

First Tracks Biotherapeutics (TRAX) is larger, with a market capitalization of $1.75B compared with $1.72B for Schrodinger (SDGR).

Are Schrodinger and First Tracks Biotherapeutics in the same industry?

Yes. Both are classified in the Biotechnology: Pharmaceutical Preparations industry within the Health Care sector.

More comparisons